Opportunistic assessment of steatotic liver disease in lung cancer screening eligible individuals
SLD is an independent predictor for long-term mortality in heavy smokers beyond known clinical risk factors.
Authors
- Hugo J.W.L. Aerts (ORCID: https://orcid.org/0000-0002-2122-2003)
- Vamsi Thiriveedhi (ORCID: https://orcid.org/0000-0002-7901-4645)
- Andriy Fedorov (ORCID: https://orcid.org/0000-0003-4806-9413)
- Michael T. Lu (ORCID: https://orcid.org/0000-0003-4696-9610)
- Simon Bernatz (ORCID: https://orcid.org/0000-0002-7758-8100)
- Jakob Weiss (ORCID: https://orcid.org/0000-0002-0336-8519)
- Raymond H. Mak
- Justin Johnson
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- University of Freiburg (DE)
- University Medical Center Freiburg (DE)
- Maastricht University (NL)
- Massachusetts General Hospital (US)
- Dana-Farber Cancer Institute (US)
- Dana-Farber Brigham Cancer Center (US)
- Mass General Brigham (US)
Publication Details
- Journal
- Journal of Internal Medicine
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1111/joim.20053
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- American College of Radiology Imaging Network
- European Commission
- Deutsche Forschungsgemeinschaft
- National Institutes of Health
- National Cancer Institute